SMi is proud to present its 6th conference on RNAi, miRNA and siRNA which shall tackle some of the most prominent issues that stand in the way of the successful harnessing of the vast potential that the process possesses. RNAi is still a new and exciting area of pharmaceutical development, however significant progress is required in certain areas, in achieving successful targeted delivery and tackling off targeting as two examples.
This conference will display some of the most promising results achieved; from structural determination through to specific therapeutic applications, clinical trial considerations and negotiating the regulatory minefield, attendees can be sure to expect an invaluable learning and networking experience.
* RNA-based therapeutics
* siRNA and oligoneucleotide delivery
* The effect of pharma cuts on RNAi
* miRNA in cardiovascular and immunology
* Bioinformatics and computational support
* Clinical trials and regulatory considerations
* Epigenetics